Supplier profile
JANSSEN CILAG, S.A.
Every public-sector award we hold for this supplier, across Colombia, Spain, France and Luxembourg, from 2 Oct 2008 to 30 Sept 2026.
Awards won
1,357
all time
Attributed value
€2.2bn + COP 22.8bn
291 shared, unvalued
Buyers
319
public bodies
Active
2008–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Dirección Gerencia del Complejo Hospitalario Universitario de Canarias | 82 | €43.1m |
| Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín | 79 | €29.5m |
| Subdirección General de Planificación y Gestión Económica | 53 | €31.1m |
| Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil | 51 | €28.8m |
| Subdirección General de Servicios Penitenciarios | 42 | €42.1m |
| Inspección General de Sanidad de la Defensa | 41 | €5.8m |
| Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria | 37 | €22.5m |
| Dirección General de Planificación Económica | 35 | €51.2m |
| Servicio Cántabro de Salud | 26 | €52.5m |
| Servicio Madrileno de Salud, Hospital Universitario La Paz | 25 | €29.0m |
What they win
Awards
Showing 601–625 of 1,357 awards we hold
- Suministro De Medicamentos De Janssen - Abiraterona (Zytiga) , Ibrutinib (Imbruvica), Ustekinumab (Stelara) - Hcd Derivado De A.M. 259/2019 - Hito 3 ↗Inspección General de Sanidad de la Defensa€227kawarded 1 Aug 2022
- Spain-Puerto del Rosario: Various medicinal products ↗Gerencia de Servicio Sanitarios de Fuerteventura€121kawarded 1 Aug 2022
- Suministro de medicamentos JANSSEN-HCD ↗Inspección General de Sanidad de la Defensa€227kawarded 1 Aug 2022
- Suministro de medicamentos antineoplásicos, anticuerpos monoclonales (Subgrupo terapéutico L01XC) ↗Subsecretaría de la Consellería de Sanidad y Salud Pública€36.6mawarded 1 Aug 2022
- Contrato basado en acuerdo marco para el suministro de medicamentos de uso humano II ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€39kawarded 27 Jul 2022
- Contrato basado en acuerdo marco para suministro de medicamentos de uso humano II ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€36kawarded 27 Jul 2022
- Contrato basado en acuerdo marco para el suministro de medicamentos de uso humano II ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€257kawarded 27 Jul 2022
- Contrato basado en acuerdo marco para el suministro de medicamentos de uso humano II ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€30kawarded 27 Jul 2022
- Contrato basado en acuerdo para el suministro de medicamentos de uso humano II ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€55kawarded 27 Jul 2022
- Suministro de Medicamentos Antipsicóticos Parenterales ↗Subsecretaría de la Consellería de Sanidad y Salud Pública€31.4mawarded 27 Jul 2022
- Contrato basado en acuerdo marco para el suministro de medicamentos de uso humano II ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€15kawarded 27 Jul 2022
- Contrato basado en acuerdo marco para el suministro de medicamentos de uso humano II ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€24kawarded 27 Jul 2022
- Spain-Madrid: Pharmaceutical products ↗SERVICIO MADRILEÑO DE SALUD - HOSPITAL UNIVERSITARIO 12 DE OCTUBRE€999kawarded 26 Jul 2022
- Spain-Madrid: Pharmaceutical products ↗Servicio Madrileño de la Salud, Hospital Universitario Ramón y Cajal€855kawarded 25 Jul 2022
- Spain-Fuenlabrada: Pharmaceutical products ↗ENTE PUBLICO HOSPITAL UNIVERSITARIO DE FUENLABRADA€470kawarded 22 Jul 2022
- Spain-Madrid: Pharmaceutical products ↗Servicio Madrileno de Salud, Hospital Universitario La Paz€83kawarded 18 Jul 2022
- Spain-Majadahonda: Pharmaceutical products ↗Hospital Universitario Puerta de Hierro de Majadahonda€1.9mawarded 15 Jul 2022
- Spain-Madrid: Pharmaceutical products ↗Servicio Madrileno de Salud, Hospital Universitario La Paz€2.7mawarded 11 Jul 2022
- TA2023 Suministro de medicamentos de Janssen-Abiraterona (Zytiga), Ibrutinib (Imbruvica), Ustekinumab (Stelara) - Derivado del Acuerdo Marco 259/2019 HCD ↗Inspección General de Sanidad de la Defensa€192kawarded 8 Jul 2022
- Spain-Barcelona: Pharmaceutical products ↗Consorci Mar Parc de Salut de Barcelonashared awardawarded 28 Jun 2022
- Suministro por exclusividad de fármaco Ustekinumab medicamento Stelara 130 mg 1 Vial INY con destino a las Farmacias hospitalarias del Área de Salud de Badajoz ↗Gerencia del Área de Salud de Badajoz€205kawarded 23 Jun 2022
- Suministro por exclusividad de fármaco Ustekinumab medicamento Stelara 90 mg. INY JER PREC con destino a las Farmacias hospitalarias del Área de Salud de Badajoz ↗Gerencia del Área de Salud de Badajoz€539kawarded 23 Jun 2022
- Spain-Vitoria-Gasteiz: Pharmaceutical products ↗Dirección General - Osakidetza€2.0mawarded 21 Jun 2022
- Spain-Madrid: Pharmaceutical products ↗SERVICIO MADRILEÑO DE SALUD - HOSPITAL UNIVERSITARIO 12 DE OCTUBRE€2.0mawarded 17 Jun 2022
- Spain-Madrid: Pharmaceutical products ↗SERVICIO MADRILEÑO DE SALUD - HOSPITAL UNIVERSITARIO 12 DE OCTUBRE€1.1mawarded 17 Jun 2022
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.